Bioyitech showcased Natural and Healthy Blood Sugar Management Solutions at FIA&NPC
With "Healthy China" now a national strategy, the health industry has seen rapid growth, and probiotics—a natural, health-focused functional food ingredient—have consistently grown. Bioyitech, under the theme "Source · Original Strain · Nation," showcased at this FIA&NPC (Booth No.: 3F28), focusing on addressing the prevalent “Four Highs” issue. Bioyitech attracted numerous industry experts for consultation by enhancing "sugar-lipid-acid" metabolism with locally adapted probiotic strains suited for Chinese gut health, earning the favor of visiting brand merchants and health management clients. Notably, Bioyitech's "Blood Sugar Management" combined strains received professional acclaim for their outstanding efficacy.
The treatment strategy for glucose metabolism disorders is multi-faceted, involving blood sugar, blood pressure, blood lipids, weight management, antiplatelet therapy, and lifestyle changes. Typically, these are divided into exercise, diet, and pharmaceutical interventions, or combinations thereof. However, compliance with standardized treatment is currently less than one-third. Can biotechnological advancements support human willpower in controlling blood sugar? Bioyitech focuses on functional probiotic strains to enhance "sugar-lipid metabolism," offering a fourth solution.
Research highlights that over half of post-meal insulin secretion is stimulated by GLP-1, a positive contributor to blood sugar stability. GLP-1, an incretin, facilitates glucose-dependent insulin secretion, inhibits glucagon secretion to lower blood sugar, delays gastric emptying, and suppresses the hypothalamic feeding center, making it a key target in diabetes research. Probiotics that stimulate endogenous GLP-1 secretion form the core of Bioyitech's "sugar reduction" strains. Collaborative experiments with partners show that combined probiotic powder interventions significantly impact long-term Type II diabetes patients. With a daily intake of 100 billion CFU of Bioyitech combined probiotic powder and real-time blood sugar monitoring via glucometers, subjects experienced narrowed blood sugar fluctuation ranges after fasting and post-meal over two weeks, approaching normal levels.
Metabolic syndrome, comprising "multiple disorders," severely impacts human health and quality of life. Bioyitech is committed to a long-term approach by selecting functional strains for metabolic management and continuously researching their functional characteristics to deepen evidence-based connections. Providing effective product solutions for the industry and offering new insights for urgent health needs and globally represents Bioyitech's original mission of "creating a good microecology, connecting to big health."